1. Home
  2. ELTX vs CAST Comparison

ELTX vs CAST Comparison

Compare ELTX & CAST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$2.18

Market Cap

63.3M

Sector

Health Care

ML Signal

HOLD

Logo FreeCast Inc. Class A Common Stock

CAST

FreeCast Inc. Class A Common Stock

N/A

Current Price

$1.30

Market Cap

65.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ELTX
CAST
Founded
2011
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
65.2M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
ELTX
CAST
Price
$2.18
$1.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$18.00
$6.00
AVG Volume (30 Days)
266.2K
8.7M
Earning Date
05-12-2026
06-26-2026
Dividend Yield
N/A
N/A
EPS Growth
39.29
N/A
EPS
N/A
N/A
Revenue
$2,301,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.34
$0.50
52 Week High
$16.00
$12.20

Technical Indicators

Market Signals
Indicator
ELTX
CAST
Relative Strength Index (RSI) 24.01 43.26
Support Level N/A $1.17
Resistance Level $3.32 $1.99
Average True Range (ATR) 0.13 0.16
MACD -0.03 0.04
Stochastic Oscillator 1.09 9.14

Price Performance

Historical Comparison
ELTX
CAST

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About CAST FreeCast Inc. Class A Common Stock

FreeCast Inc is a streaming technology company that provides platform-as-a-service solutions for television and digital video distribution. Its platform infrastructure supports telecom operators, internet service providers, broadcasters, municipalities, utilities, brands, and device manufacturers in deploying and managing digital media and streaming services.

Share on Social Networks: